Fibrinogen and LDL Apheresis in Treatment of Sudden Hearing Loss: A Randomised Multicentre Trial

December 2002 in “ The Lancet ”

M. Suckfüll

fibrinogen LDL apheresis sudden sensorineural hearing loss SSHL pure-tone thresholds speech perception plasma fibrinogen serum LDL

Studysummary In this study, single fibrinogen/LDL apheresis showed a significant improvement in speech perception for patients with plasma fibrinogen concentrations over 295 mg/dL compared to standard treatment for sudden sensorineural hearing loss.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on thelancet.com →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research Les nouvelles stratégies thérapeutiques du traumatisme sonore par bruit d'arme chez le cobaye

January 2010 in “HAL (Le Centre pour la Communication Scientifique Directe)”

This study found that intra-cochlear administration of z-VAD-FMK for 7 days after gunshot noise trauma in guinea pigs accelerated hearing recovery and preserved hair cell survival.

research Platelet‐rich fibrin: A review of its role as a new treatment in androgenetic alopecia

April 2024 in “Journal of cosmetic dermatology”

This article discusses the development of liquid platelet-rich fibrin as a potential improvement over platelet-rich plasma for treating androgenetic alopecia and reports no new clinical results.

research Injectable platelet-rich fibrin for treatment of female pattern hair loss

May 2024 in “Journal of Cosmetic and Laser Therapy”

This study found that three sessions of injectable platelet-rich fibrin (i-PRF+) significantly improved hair follicle density, hair volume, and thickness, as well as patient satisfaction in women with female pattern hair loss, with only minor self-limited adverse effects reported.

research Evaluation of using stromal vascular fraction and platelet rich plasma in the treatment of androgenetic alopecia

March 2020 in “QJM: An International Journal of Medicine”

In this study, significant improvements in Androgenetic Alopecia were observed with both PRP and SVF therapies, with SVF showing greater effectiveness in increasing terminal and vellus hair counts.

New Tool in Our Arsenal: Efficacy of Injectable Platelet-Rich Fibrin in Androgenetic Alopecia Treatment

research New tool in our arsenal: efficacy of injectable platelet-rich fibrin (i-PRF) in androgenetic alopecia treatment

February 2025 in “Archives of Dermatological Research”

In this study, researchers administered injectable platelet-rich fibrin (i-PRF) to 30 patients with androgenetic alopecia, finding an 80% response rate after 6 months, with improved hair density and reduced scalp symptoms, while reporting minimal adverse reactions.